Cédric Révil

Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study

Bella Kaufman, John R. Mackey, Michael Clemens et al. · Journal of Clinical Oncology · 2009 · 848 citations · Full text

Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma

Wolfgang Wick, Olivier Chinot, Martin Bendszus et al. · Neuro-Oncology · 2016 · 95 citations · Full text

Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio

Olivier Chinot, Ryo Nishikawa, Warren Mason et al. · Neuro-Oncology · 2016 · 39 citations · Full text

Radiologic progression of glioblastoma under therapy—an exploratory analysis of AVAglio

Martha Nowosielski, Benjamin M. Ellingson, Olivier Chinot et al. · Neuro-Oncology · 2017 · 33 citations · Full text

Clinical and Cost Effectiveness of Bevacizumab + FOLFIRI Combination Versus FOLFIRI Alone as First-Line Treatment of Metastatic Colorectal Cancer in South Korea

Eui‐Kyung Lee, Cédric Révil, C.A. Ngoh et al. · Clinical Therapeutics · 2012 · 18 citations

Surgical Oncology, Gastrointestinal Oncology, South Korea +8